Rigel Pharmaceuticals Inc

12. Nov. 2026, 21:07 UTC

Rigel Pharmaceuticals, Inc. shares advanced during Thursday's session, despite earlier pulling back, following the release of disappointing earnings for the year ending September 2026.

10. Nov. 2026, 21:07 UTC

Rigel Pharmaceuticals CEO Raul Rodriguez will present at the Jefferies Global Healthcare Conference on November 17, 2026, discussing therapies for hematologic disorders and cancer.

9. Nov. 2026, 21:03 UTC

Rigel Pharmaceuticals, Inc. shares rose sharply after Citigroup maintained a Buy rating and raised its price target to $86 from $83, amid high trading volume.

6. Nov. 2026, 21:02 UTC

Rigel Pharmaceuticals reported Q3 EPS of $0.65, below the $0.96 estimate, and adjusted FY 2026 sales guidance to $290M-$295M, missing expectations.

5. Nov. 2026, 23:56 UTC

Rigel Pharmaceuticals reports Q3 2026 net income of $13.2 million, missing expectations, and revises full-year revenue guidance down to $290-$295 million.

4. Nov. 2026, 21:07 UTC

Rigel Pharmaceuticals will present updated data from its Phase 1b clinical study of R289 at the American Society of Hematology Annual Meeting on December 12, 2026.

3. Nov. 2026, 21:07 UTC

Rigel Pharmaceuticals, Inc. shares are declining, continuing a trend of weaker performance over the past three sessions amid overall market volatility.

2. Nov. 2026, 20:56 UTC

Rigel Pharmaceuticals, Inc. shares fell over one percent after pulling back from an earlier session high, though they remain above the 20-day moving average.

30. Okt. 2026, 23:06 UTC

Rigel Pharmaceuticals, Inc. shares declined sharply during after-market hours, reaching their lowest point since Friday's close amid a broader market decline.

29. Okt. 2026, 21:02 UTC

Rigel Pharmaceuticals, Inc. is declining in after-market trading, falling significantly since Thursday's close.

22. Okt. 2026, 20:07 UTC

Rigel Pharmaceuticals Inc's shares are slightly higher, maintaining a position above the 20-day moving average amid broader market gains.

21. Okt. 2026, 20:07 UTC

Rigel Pharmaceuticals Inc. shares advanced on Wednesday, continuing a trend of higher daily finishes and remaining above their 20-day moving average.

20. Okt. 2026, 20:08 UTC

Rigel Pharmaceuticals Inc will present pooled efficacy and safety data from two clinical trials of GAVRETO® at the European Society For Medical Oncology Congress on October 25, 2026.

19. Okt. 2026, 20:07 UTC

Rigel Pharmaceuticals reported positive GAVRETO data at ESMO, showing a 53% overall response rate in RET fusion-positive solid tumors, with HC Wainwright reiterating a Buy rating.

15. Okt. 2026, 19:56 UTC

Rigel Pharmaceuticals Inc is trading higher, rebounding after three sessions of declines, supported by strength in the broader biotechnology sector.

14. Okt. 2026, 21:31 UTC

Rigel Pharmaceuticals Inc is experiencing a significant decline in after-market trading, continuing a trend of four consecutive sessions finishing lower.

13. Okt. 2026, 19:16 UTC

Rigel Pharmaceuticals Inc shares fell, continuing a notable decline since Monday's close amid unusual activity, with prices around the middle of their one-month range.

8. Okt. 2026, 20:01 UTC

Rigel Pharmaceuticals Inc is trading higher, reaching a peak return after initial declines, currently above its 20-day moving average and near the upper end of its one-month range.

7. Okt. 2026, 20:01 UTC

Rigel Pharmaceuticals Inc is seeing a higher trading session today, marked by unusually high share volume, diverging from its recent upward trend since Tuesday.

6. Okt. 2026, 20:06 UTC

Rigel Pharmaceuticals Inc shares fell sharply, continuing a downward trend since Monday, with the price remaining well below its 20-day moving average.

5. Okt. 2026, 21:01 UTC

Rigel Pharmaceuticals Inc is trading lower in after-market hours, extending a decline that started at Monday's close amid a notably quiet session.

1. Okt. 2026, 20:07 UTC

Rigel Pharmaceuticals Inc shares fell sharply, closing significantly lower amid consistent pressure and a four-session losing streak below the 20-day moving average.

24. Sept. 2026, 20:07 UTC

Rigel Pharmaceuticals Inc shares fell, continuing a downward trend since Wednesday, despite a midday recovery, remaining below their opening level.

23. Sept. 2026, 20:07 UTC

Rigel Pharmaceuticals Inc shares fell sharply amid a declining broader market, reaching a low of nearly 3.75% below Tuesday's close before a slight recovery.

18. Sept. 2026, 20:02 UTC

Rigel Pharmaceuticals Inc is advancing today with unusually high trading activity, breaking from a recent trend of higher daily closes since Thursday.

15. Sept. 2026, 20:02 UTC

Rigel Pharmaceuticals is trading lower as the NY Empire State Manufacturing Index fell sharply, raising concerns about economic contraction in New York's manufacturing sector.

11. Sept. 2026, 19:46 UTC

Rigel Pharmaceuticals is higher today, influenced by CPI data and speculation about potential Federal Reserve interest rate hikes. The stock remains near its one-month trading range.

10. Sept. 2026, 23:21 UTC

Rigel Pharmaceuticals Inc is rising in after-market trading, reversing a three-session decline. No specific news was identified to explain this price action.

8. Sept. 2026, 20:07 UTC

Rigel Pharmaceuticals Inc shares are lower today, continuing a decline since Friday. The stock saw notable volatility but remains above its 20-day moving average.

1. Sept. 2026, 20:08 UTC

Rigel Pharmaceuticals Inc shares are higher today, reflecting strong market performance and robust momentum above the 20-day moving average. No specific news was identified.